Taylor Brooks, Adrienne Nedved, Yucai Wang, Natalie Grover, Xi Yang, Yasmin Karimi, Tenley Schwarz, Matthew Schwede, Marshall McKenna, Yun Kyoung Tiger, Nayef Abdel-Razeq, Muhamad Alhaj Moustafa, Catherine Reinert, Ajay Major, Daniel Trotier, Priyanka Pophali, Kelsey Baron, Boyu Hu, Sally Jones, Aditi Saha, Nikita Dave, Daniel Landsburg, Megan Sears-Smith, Nilanjan Ghosh, Kiarash Salafian, Emily Ayers, Suchitra Sundaram, Joshua Brody, Alyssa Gibson, Justin Kline, Javier Muñoz, Rodolfo Garza Morales, Eiraj Khan, Cyrus Khan, Brenda Castillo, Stephen Smith, Fadzai Chinyengetere, Sandeep Dave, Alex Niu, Francisco Hernandez-Ilizaliturri, Paolo Caimi, Brian Hill. "Twelve month landmark analysis of outcomes of relapsed or refractory large B-cell lymphoma patients achieving prolonged remission with glofitamab or epcoritamab in the real-world outcomes of bispecific T-cell engagers (REALBiTE) multi-center, retrospective cohort study." Blood, 2025. doi:10.1182/blood-2025-4499